This consensus review article considers the question of whether glucocorticoid (GC) therapy is still relevant in the treatment of rheumatic diseases, with a particular focus on rheumatoid arthritis (RA), and whether its side effects can be adequately managed. Recent basic and clinical research on the molecular, cellular and clinical effects of GCs have considerably advanced our knowledge in this field. An overview of the subject seems appropriate.

Balancing benefits and risks of glucocorticoids in rheumatic diseases and other inflammatory joint disorders: new insights from emerging data. An expert consensus paper from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) / Cooper, C; Bardin, T; Brandi, Ml; Cacoub, P; Caminis, J; Civitelli, R; Cutolo, M; Dere, W; Devogelaer, Jp; Diez-Perez, A; Einhorn, Ta; Emonts, P; Ethgen, O; Kanis, Ja; Kaufman, Jm; Kvien, Tk; Lems, Wf; Mccloskey, E; Miossec, P; Reiter, S; Ringe, J; Rizzoli, R; Saag, K; Reginster, Jy.. - In: AGING CLINICAL AND EXPERIMENTAL RESEARCH. - ISSN 1720-8319. - ELETTRONICO. - 8:(2016), pp. 1-1.

Balancing benefits and risks of glucocorticoids in rheumatic diseases and other inflammatory joint disorders: new insights from emerging data. An expert consensus paper from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO).

BRANDI, MARIA LUISA;
2016

Abstract

This consensus review article considers the question of whether glucocorticoid (GC) therapy is still relevant in the treatment of rheumatic diseases, with a particular focus on rheumatoid arthritis (RA), and whether its side effects can be adequately managed. Recent basic and clinical research on the molecular, cellular and clinical effects of GCs have considerably advanced our knowledge in this field. An overview of the subject seems appropriate.
2016
8
1
1
Cooper, C; Bardin, T; Brandi, Ml; Cacoub, P; Caminis, J; Civitelli, R; Cutolo, M; Dere, W; Devogelaer, Jp; Diez-Perez, A; Einhorn, Ta; Emonts, P; Ethgen, O; Kanis, Ja; Kaufman, Jm; Kvien, Tk; Lems, Wf; Mccloskey, E; Miossec, P; Reiter, S; Ringe, J; Rizzoli, R; Saag, K; Reginster, Jy.
File in questo prodotto:
File Dimensione Formato  
Balancing benefits and risks of glucocorticoids in 2016.pdf

Accesso chiuso

Tipologia: Pdf editoriale (Version of record)
Licenza: Tutti i diritti riservati
Dimensione 799.08 kB
Formato Adobe PDF
799.08 kB Adobe PDF   Richiedi una copia

I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificatore per citare o creare un link a questa risorsa: https://hdl.handle.net/2158/1017099
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 21
  • ???jsp.display-item.citation.isi??? 12
social impact